SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
MRMD

Marimed Inc. (OTC:MRMD)

US · Delayed Price · Currency is USD
Also listed: MRMD.CNHealthcare · Drug Manufacturers - Specialty & Generic
$0.05+$0.00 (-4.08%)
 
Market cap
$19.1M
Insider Score
Health Score
Analyst consensus
Listed since
Aug 3, 2012
Market Cap$19.08M-43.8%
Revenue (ttm)$167.28M+6.3%
Net Income-$15.51M+13.2%
EPS-$0.04+16.5%
Shares Out406.00M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume100,441
Open$0.05
Previous Close$0.05
Day's Range$0.05 - $0.05
52-Week Range$0.04 - $0.16
Beta1.40
AnalystsBuy
Price Target$2.25(+4687.23%)
Earnings DateMar 17, 2027
+2.04% (1D)
No price history available.

About MRMD

MariMed Inc. operates in the cannabis industry, specializing in the cultivation, production, and sale of both medicinal and adult-use cannabis items throughout the United States and internationally. The company's diverse product portfolio includes cannabis flowers and concentrates marketed under the Nature's Heritage brand. It also offers infused goods such as chewable tablets and powdered drink mixes under the Kalm Fusion label, natural fruit chews known as Betty's Eddies, and a line of baked treats like brownies and cookies available through Bubby's Baked. Furthermore, MariMed develops cannabidiol (CBD) products under the Florance brand. Beyond its own offerings, the company licenses its various brands and product formulations to others and leases facilities designed for cannabis operations. MariMed Inc., founded in 2011, is based in Norwood, Massachusetts.

Address
10 Oceana Way, Norwood, MA, 02062, US
Market Cap
19 million
Employees
866
Industrial Classification
Drug Manufacturers - Specialty & Generic
Financial Health Score
Fair
From MRMD’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-4.08%
5 Days
-30.88%
1 Month
-16.07%
6 Months
-37.33%
1 Year
-43.78%

$MRMD stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in MRMD holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by MRMD's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

MRMD Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New MRMD patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to MRMD from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in MRMD

MSOSAdvisorShares Pure US Cannabis ETF$333.28K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from MRMD’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
90
News & Sentiment
20% of score
72

News check: Q3 2026 earnings beat with record revenue and positive GF Value upside estimates drive bullish coverage, though limited detail on forward guidance.

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

MSOSAdvisorShares Pure US Cannabis ETF0.05%

Weight is the stock’s share of each fund’s holdings.